Literature DB >> 14644985

Morphine for management of refractory dyspnoea: opiates should be used with caution.

James W Berrill, Seamus J Linnasne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14644985      PMCID： PMC286294          DOI： 10.1136/bmj.327.7426.1288-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

2.  Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea.

Authors:  Amy P Abernethy; David C Currow; Peter Frith; Belinda S Fazekas; Annie McHugh; Chuong Bui
Journal:  BMJ       Date:  2003-09-06
  2 in total
  3 in total

Review 1.  Management of dyspnea in patients with chronic obstructive pulmonary disease.

Authors:  Amy P Abernethy; Hope E Uronis; Jane L Wheeler; David C Currow
Journal:  Wien Med Wochenschr       Date:  2009-12

2.  Using laboratory models to test treatment: morphine reduces dyspnea and hypercapnic ventilatory response.

Authors:  Robert B Banzett; Lewis Adams; Carl R O'Donnell; Sean A Gilman; Robert W Lansing; Richard M Schwartzstein
Journal:  Am J Respir Crit Care Med       Date:  2011-07-21       Impact factor: 21.405

3.  8-OH-DPAT abolishes the pulmonary C-fiber-mediated apneic response to fentanyl largely via acting on 5HT1A receptors in the nucleus tractus solitarius.

Authors:  Jianguo Zhuang; Zhenxiong Zhang; Cancan Zhang; Fadi Xu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-06-13       Impact factor: 3.619
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.